TABLE 2.
Antibiotic susceptibilities of nasal isolates obtained from NMP or MPa
| Antibiotic | NMP (n = 16) | MP (n = 35) | P values |
|---|---|---|---|
| No. (%) of isolates resistant | No. (%) of isolates resistant | ||
| Amikacin | 0 (0.0) | 0 (0.0) | |
| Ampicillin | 15 (93.8) | 32 (91.4) | 1.00 |
| Cephalothin | 0 (0.0) | 4 (11.4) | 0.30 |
| Clindamycin | 1 (6.3) | 5 (14.3) | 0.65 |
| Erythromycin | 4 (25.0) | 17 (48.6) | 0.11 |
| Gentamicin | 0 (0.0) | 4 (11.4) | 0.30 |
| Levofloxacin | 0 (0.0) | 9 (25.7) | 0.04 |
| Oxacillin | 2 (12.5) | 7 (20.0) | 0.70 |
| Penicillin | 15 (93.8) | 32 (91.4) | 1.00 |
| Rifampin | 0 (0.0) | 0 (0.0) | |
| Trimethoprim-sulfamethoxazole | 0 (0.0) | 5 (14.3) | 0.17 |
| Vancomycin | 0 (0.0) | 0 (0.0) |
a
A total of 51 isolates were tested. One isolate was unavailable for susceptibility testing.